AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27097389 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between groups at third month measurements
Number of subjects: 98
Study 25494702 — intervention group
Group type: EXPERIMENTAL
Intervention: EmPhAsIS intervention (patient asthma education, SMS-based monthly adherence assessment, follow-up by pharmacists)
Number of subjects: 0
Study 25494702 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 25494702 — intervention group
Group type: EXPERIMENTAL
Intervention: EmPhAsIS intervention
Number of subjects: 0
Study 22761527 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated patient case
Number of subjects: 0
Study 22761527 — intervention group
Group type: COMPARATOR
Intervention: Written patient case
Number of subjects: 0
Study 20882405 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid 1 mg IV weekly for 4 doses
Number of subjects: 60
Study 20882405 — intervention group
Group type: COMPARATOR
Intervention: Single dose of zoledronic acid 4 mg IV
Number of subjects: 60
Study 20882405 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronomic low‐dose zoledronic acid
Number of subjects: 60
Study 19022840 — intervention group
Group type: EXPERIMENTAL
Intervention: Faecal occult blood test
Number of subjects: 106000
Study 19022840 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening episode
Number of subjects: 106000
Study 19022840 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening programme
Number of subjects: 106000
Study 19022840 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 106000
Study 15812609 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-session intervention provided to the woman and her sexual partner together (n=81)
Number of subjects: 217
Study 15812609 — intervention group
Group type: EXPERIMENTAL
Intervention: Same intervention provided to the woman alone (n=73)
Number of subjects: 217
Study 15812609 — intervention group
Group type: COMPARATOR
Intervention: One-session health information education control provided to the woman alone (n=63)
Number of subjects: 217
Study 12419572 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (6 g)
Number of subjects: 35
Study 12419572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 10489950 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL bivalent intravenous scorpion antivenom
Number of subjects: 825
Study 10489950 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 825
Study 8598700 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim-mobilised PBPC
Number of subjects: 58
Study 8598700 — intervention group
Group type: COMPARATOR
Intervention: Autologous bone marrow transplantation (ABMT)
Number of subjects: 58
Study 2018165 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetorphan
Number of subjects: 19
Study 2018165 — intervention group
Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 19
Study 7037524 — intervention group
Group type: EXPERIMENTAL
Intervention: Propylthiouracil
Number of subjects: 67
Study 7037524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 30385397 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical estrogen
Number of subjects: 43
Study 30385397 — intervention group
Group type: COMPARATOR
Intervention: Topical emollient
Number of subjects: 43
Study 27097156 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafiltration (UF)
Number of subjects: 77
Study 27097156 — intervention group
Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 77
Study 27421051 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate ART initiation
Number of subjects: 514
Study 27421051 — intervention group
Group type: COMPARATOR
Intervention: National guidelines recommended initiation (CD4≤350 cells/mm(3))
Number of subjects: 514
Study 24045673 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 249
Study 24045673 — intervention group
Group type: COMPARATOR
Intervention: Usual activity
Number of subjects: 249
Study 21989330 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapatinib plus capecitabine
Number of subjects: 234
Study 21989330 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine
Number of subjects: 234
Study 19509162 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg oral docetaxel with ritonavir
Number of subjects: 12
Study 19509162 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg oral docetaxel with ritonavir (simultaneously)
Number of subjects: 12
Study 19509162 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg oral docetaxel with ritonavir (60 minutes before)
Number of subjects: 12
Study 19509162 — intervention group
Group type: COMPARATOR
Intervention: 100 mg i.v. docetaxel
Number of subjects: 12
Study 17311980 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics with standard antibiotic treatment
Number of subjects: 9
Study 17311980 — intervention group
Group type: COMPARATOR
Intervention: Probiotics
Number of subjects: 9
Study 15750041 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated protein C (APC) 24 microg/kg/hour
Number of subjects: 15
Study 15750041 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 15
Study 12430993 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning training
Number of subjects: 14
Study 12430993 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening training
Number of subjects: 14
Study 12430993 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 14
Study 10327910 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (mean daily dose 202 mg, SD = 86)
Number of subjects: 92
Study 10327910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 10327910 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 92
Study 7481338 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant regimen (vitamin E, vitamin C, and N-acetylcysteine)
Number of subjects: 24
Study 7481338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 1683420 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunscreen applied before UV exposure
Number of subjects: 38
Study 1683420 — intervention group
Group type: COMPARATOR
Intervention: Placebo applied before UV exposure
Number of subjects: 38
Study 6980782 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific immunotherapy with bacterial allergens (E. coli, proteus, staphylococcus, streptococcus)
Number of subjects: 1000
Study 29624807 — intervention group
Group type: EXPERIMENTAL
Intervention: Meaning-centered group psychotherapy for cancer survivors (MCGP-CS)
Number of subjects: 170
Study 29624807 — intervention group
Group type: COMPARATOR
Intervention: Supportive group psychotherapy (SGP)
Number of subjects: 170
Study 29624807 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (CAU)
Number of subjects: 170
Study 26962728 — intervention group
Group type: COMPARATOR
Intervention: Sulfadoxine‐pyrimethamine (106 participants)
Number of subjects: 300
Study 26962728 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dose dihydroartemisinin‐piperaquine (94 participants)
Number of subjects: 300
Study 26962728 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly dihydroartemisinin‐piperaquine (100 participants)
Number of subjects: 300
Study 24732918 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg verapamil
Number of subjects: 591
Study 24732918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 591
Study 22406977 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 96
Study 20696047 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive BP lowering to a target of 130 mmHg systolic (or by 10 mmHg if baseline systolic pressure is between 125 and 140 mmHg)
Number of subjects: 610
Study 20696047 — intervention group
Group type: COMPARATOR
Intervention: Standard BP lowering to a target of 140 mmHg systolic
Number of subjects: 610
Study 20696047 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive BP lowering
Number of subjects: 610
Study 20696047 — intervention group
Group type: COMPARATOR
Intervention: Standard BP lowering
Number of subjects: 610
Study 18446124 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic scalpel (Group A)
Number of subjects: 101
Study 18446124 — intervention group
Group type: COMPARATOR
Intervention: High-frequency electrocautery (Group B)
Number of subjects: 101
Study 16772805 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled thoracic epidural analgesia
Number of subjects: 120
Study 12882706 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine chemotherapy plus thalidomide (A)
Number of subjects: 38
Study 12882706 — intervention group
Group type: COMPARATOR
Intervention: Routine chemotherapy alone (B)
Number of subjects: 38
Study 12882706 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine chemotherapy plus thalidomide (C) for relapsing cases
Number of subjects: 38
Study 12882706 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide group
Number of subjects: 38
Study 10999794 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg daily
Number of subjects: 350
Study 10999794 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 5 mg daily
Number of subjects: 350
Study 10999794 — intervention group
Group type: COMPARATOR
Intervention: Placebo (after 5 years of alendronate)
Number of subjects: 350
Study 9038459 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg intravenously
Number of subjects: 60
Study 9038459 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron 8 mg intravenously
Number of subjects: 60
Study 1792593 — intervention group
Group type: EXPERIMENTAL
Intervention: Theopec (TP)
Number of subjects: 64
Study 1792593 — intervention group
Group type: EXPERIMENTAL
Intervention: Theobiolong (TB)
Number of subjects: 64
Study 6414626 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaflet provided to patients prescribed penicillins (56 patients)
Number of subjects: 99
Study 6414626 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaflet provided to patients prescribed non-steroidal anti-inflammatory drugs (43 patients)
Number of subjects: 99
Study 6414626 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaflet provided to patients (both groups)
Number of subjects: 99
Study 6414626 — intervention group
Group type: COMPARATOR
Intervention: No leaflet provided (Control group: 65 patients prescribed penicillin and 33 prescribed non-steroidal anti-inflammatory drugs)
Number of subjects: 99
Study 30831101 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepivacaine 1% 10 mL intrauterine instillation
Number of subjects: 86
Study 30831101 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl (placebo) intrauterine instillation
Number of subjects: 86
Study 28430315 — intervention group
Group type: EXPERIMENTAL
Intervention: QA-based surveillance (measured quarterly using Doppler ultrasound and ultrasound dilution)
Number of subjects: 207
Study 28430315 — intervention group
Group type: COMPARATOR
Intervention: Control group (surveillance based on classic alarm criteria)
Number of subjects: 207
Study 25736569 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS and conventional physical therapy
Number of subjects: 24
Study 25736569 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation and conventional physical therapy
Number of subjects: 24
Study 25749597 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cancer recovery (MBCR)
Number of subjects: 271
Study 25749597 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive-expressive therapy (SET)
Number of subjects: 271
Study 25749597 — intervention group
Group type: COMPARATOR
Intervention: 1-day stress management seminar (SMS)
Number of subjects: 271
Study 21883497 — intervention group
Group type: COMPARATOR
Intervention: Dietary manganese concentration of 0.24 mg/kg
Number of subjects: 36
Study 21883497 — intervention group
Group type: COMPARATOR
Intervention: Dietary manganese concentration of 2 mg/kg
Number of subjects: 36
Study 21883497 — intervention group
Group type: COMPARATOR
Intervention: Dietary manganese concentration of 4 mg/kg
Number of subjects: 36
Study 21883497 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary manganese concentration of 16 mg/kg
Number of subjects: 36
Study 21883497 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary manganese concentration of 32 mg/kg
Number of subjects: 36
Study 18240114 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical music
Number of subjects: 21
Study 18240114 — intervention group
Group type: EXPERIMENTAL
Intervention: Techno music
Number of subjects: 21
Study 18240114 — intervention group
Group type: EXPERIMENTAL
Intervention: Music for relaxation
Number of subjects: 21
Study 18240114 — intervention group
Group type: COMPARATOR
Intervention: No music
Number of subjects: 21
Study 17531542 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiepileptic medication
Number of subjects: 21
Study 17531542 — intervention group
Group type: COMPARATOR
Intervention: Control (mild asthma)
Number of subjects: 21
Study 15207950 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg
Number of subjects: 116
Study 15207950 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 11790414 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 21
Study 11790414 — intervention group
Group type: EXPERIMENTAL
Intervention: (-)-hydroxycitrate (HCA)
Number of subjects: 21
Study 11790414 — intervention group
Group type: EXPERIMENTAL
Intervention: (-)-hydroxycitrate combined with medium-chain triglycerides (HCA+MCT)
Number of subjects: 21
Study 9710873 — intervention group
Group type: EXPERIMENTAL
Intervention: Submaximal all-extremity exercise test using the Pro II Power Trainer
Number of subjects: 0
Study 9710873 — intervention group
Group type: COMPARATOR
Intervention: Treadmill test
Number of subjects: 0
Study 8035981 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.2-mm incision
Number of subjects: 200
Study 8035981 — intervention group
Group type: COMPARATOR
Intervention: 5.5-mm incision
Number of subjects: 200
Study 3140860 — intervention group
Group type: EXPERIMENTAL
Intervention: FIO2 of 0.5 (50% oxygen)
Number of subjects: 35
Study 3140860 — intervention group
Group type: COMPARATOR
Intervention: FIO2 of 0.33 (33% oxygen)
Number of subjects: 35
Study 30683080 — intervention group
Group type: EXPERIMENTAL
Intervention: salvational intervention (SI group) with budesonide/formoterol (160μg/4.5μg once b.i.d) from the first day after severe air pollution (AQI ≥200) to the third day after AQI < 200
Number of subjects: 764
Study 30683080 — intervention group
Group type: COMPARATOR
Intervention: Control group (CT group) maintaining original treatment (tiotropium and/or budesonide/formoterol)
Number of subjects: 764
Study 28137703 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized EAT intervention (90 minutes of mentoring in a classroom setting)
Number of subjects: 1500
Study 28137703 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 1500
Study 28137703 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized EAT intervention
Number of subjects: 1500
Study 26218111 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia education (10-minute video on the value of CEEs)
Number of subjects: 459
Study 26218111 — intervention group
Group type: COMPARATOR
Intervention: Control (no video, not retested)
Number of subjects: 459
Study 26218111 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Intervention and Control)
Number of subjects: 459
Study 26218111 — intervention group
Group type: EXPERIMENTAL
Intervention: Free CEEs offered
Number of subjects: 459
Study 22459589 — intervention group
Group type: EXPERIMENTAL
Intervention: Open dismembered pyeloplasty with pelvic reduction (group A)
Number of subjects: 40
Study 22459589 — intervention group
Group type: COMPARATOR
Intervention: Pelvis-sparing pyeloplasty (group B)
Number of subjects: 40
Study 21824709 — intervention group
Group type: EXPERIMENTAL
Intervention: 4000 IU of hCG (Group A)
Number of subjects: 164
Study 21824709 — intervention group
Group type: EXPERIMENTAL
Intervention: 6000 IU of hCG (Group B)
Number of subjects: 164
Study 21824709 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of u-hCG
Number of subjects: 164
Study 19061964 — intervention group
Group type: EXPERIMENTAL
Intervention: Speech pathology intervention (multidimensional treatment programme including education, vocal hygiene training, cough suppression strategies, psychoeducational counseling)
Number of subjects: 87
Study 16696745 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 30 mg once weekly for 12 weeks
Number of subjects: 60
Study 16696745 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 16696745 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D 400 IU daily
Number of subjects: 60
Study 15093199 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation of the whole breast delivering 50 Gy in 25 fractions
Number of subjects: 0
Study 15093199 — intervention group
Group type: EXPERIMENTAL
Intervention: Boost of the tumor bed
Number of subjects: 0
Study 15093199 — intervention group
Group type: EXPERIMENTAL
Intervention: External radiation therapy
Number of subjects: 0
Study 11230034 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 2045
Study 11230034 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRIs
Number of subjects: 2045
Study 11230034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2045
Study 10198510 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot repeat dispensing system by community pharmacists
Number of subjects: 0
Study 7920871 — intervention group
Group type: EXPERIMENTAL
Intervention: L-dopa with pyridostigmine pretreatment in obese subjects
Number of subjects: 17
Study 7920871 — intervention group
Group type: EXPERIMENTAL
Intervention: L-dopa with pyridostigmine pretreatment in control subjects
Number of subjects: 17
Study 7920871 — intervention group
Group type: EXPERIMENTAL
Intervention: L-dopa only in obese subjects
Number of subjects: 17
Study 7920871 — intervention group
Group type: COMPARATOR
Intervention: L-dopa only in control subjects
Number of subjects: 17
Study 7920871 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine
Number of subjects: 17
Study 7920871 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma insulin and FFA levels in obese subjects
Number of subjects: 17
Study 7920871 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index correlation
Number of subjects: 17
Study 7920871 — intervention group
Group type: EXPERIMENTAL
Intervention: GH AUC correlation
Number of subjects: 17
Study 7920871 — intervention group
Group type: EXPERIMENTAL
Intervention: FFA influence on GH AUC
Number of subjects: 17
Study 3241870 — intervention group
Group type: EXPERIMENTAL
Intervention: Real beer
Number of subjects: 2
Study 3241870 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 30204280 — intervention group
Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 1935
Study 30204280 — intervention group
Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 1935
Study 30204280 — intervention group
Group type: EXPERIMENTAL
Intervention: baseline GDF-15
Number of subjects: 1935
Study 30204280 — intervention group
Group type: EXPERIMENTAL
Intervention: changes in GDF-15
Number of subjects: 1935
Study 27765708 — intervention group
Group type: EXPERIMENTAL
Intervention: New slump sitting method for lumbar spine flexion radiographs
Number of subjects: 60
Study 27765708 — intervention group
Group type: COMPARATOR
Intervention: Conventional method for lumbar spine flexion radiographs
Number of subjects: 60
Study 25766947 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised Exercise (SE)
Number of subjects: 111
Study 25766947 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent Revascularization (ST)
Number of subjects: 111
Study 25766947 — intervention group
Group type: COMPARATOR
Intervention: Optimal Medical Care (OMC)
Number of subjects: 111
Study 23349422 — intervention group
Group type: EXPERIMENTAL
Intervention: Open technique with free eruption (n = 22)
Number of subjects: 43
Study 23349422 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed technique (n = 21)
Number of subjects: 43
Study 23349422 — intervention group
Group type: COMPARATOR
Intervention: Contralateral quadrants with normally erupted canines
Number of subjects: 43
Study 21211545 — intervention group
Group type: EXPERIMENTAL
Intervention: Attractive faces
Number of subjects: 263
Study 21211545 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of caries
Number of subjects: 263
Study 21211545 — intervention group
Group type: COMPARATOR
Intervention: Unattractive faces
Number of subjects: 263
Study 21211545 — intervention group
Group type: COMPARATOR
Intervention: Neither unattractive nor attractive faces
Number of subjects: 263
Study 18462564 — intervention group
Group type: EXPERIMENTAL
Intervention: FSC 100/50 mcg
Number of subjects: 475
Study 18462564 — intervention group
Group type: COMPARATOR
Intervention: FP 100 mcg
Number of subjects: 475
Study 16814013 — intervention group
Group type: EXPERIMENTAL
Intervention: DUI court intervention
Number of subjects: 0
Study 16814013 — intervention group
Group type: COMPARATOR
Intervention: Traditional court expenditures for second-time offenders
Number of subjects: 0
Study 15748068 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits by trained members of the Iraqi Women's Federation during the 2-month initial phase of DOTS treatment
Number of subjects: 172
Study 15748068 — intervention group
Group type: COMPARATOR
Intervention: Control group attending local health centre for treatment
Number of subjects: 172
Study 11849851 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent implantation with complete revascularization
Number of subjects: 1205
Study 11849851 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent implantation with incomplete revascularization
Number of subjects: 1205
Study 11849851 — intervention group
Group type: EXPERIMENTAL
Intervention: Bypass surgery with complete revascularization
Number of subjects: 1205
Study 11849851 — intervention group
Group type: EXPERIMENTAL
Intervention: Bypass surgery with incomplete revascularization
Number of subjects: 1205
Study 11849851 — intervention group
Group type: COMPARATOR
Intervention: Bypass surgery
Number of subjects: 1205
Study 9701195 — intervention group
Group type: EXPERIMENTAL
Intervention: Trace element supplementation (40.4 micromol Cu, 2.9 micromol Se, and 406 micromol Zn; group TE)
Number of subjects: 20